Research Article

Aberrant right subclavian artery: is a strong marker for Down syndrome and congenital heart disease?

Volume: 14 Number: 1 January 4, 2021
EN TR

Aberrant right subclavian artery: is a strong marker for Down syndrome and congenital heart disease?

Abstract

Purpose: The association between fetal aberrant right subclavian artery (ARSA) and Down syndrome has been known for a long time. The aim of our study was to determine the incidence of ARSA in our population and its association with Down syndrome and congenital heart diseases (CHD). Materials and Methods: Between 2015-2018 years, fetal echocardiography was performed in 3150 pregnant population at a tertiary referral center for prenatal diagnosis. The presence of ARSA was verified by visualization of the transverse 3-vessel trachea view by color Doppler sonography during fetal echocardiography. The frequency of ARSA and its correlation with Down syndrome were investigated in our study. Results: Among the 3150 patients, an ARSA was detected in 42 fetuses (1.3%) and isolated ARSA was detected in 36 fetuses (1.14%). Of nine fetuses with Down syndrome, ARSA was positive in two (22.2%). ARSA was positive in only one of the fetuses with CHD (4.1%). The positive likelihood ratios of isolated ARSA for Down syndrome and CHD were 0.73 and 3.81, respectively. Conclusion: In our case series, prenatal detection of ARSA does not appear to be a strong marker alone of Down syndrome and the isolated ARSA shows a weak association with CHD.

Keywords

References

  1. Referans1 Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983;249:2034–2038. doi:10.1001/jama.1983.03330390038028
  2. Referans2 Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 2013;41:247-261. doi: 10.1002/uog.12364. Epub 2013 Jan 24.
  3. Referans3 Freeman SB, Taft LF, Dooley KJ, Allran K, Sherman SL, Hassold TJ, Khoury MJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998;80:213-7.
  4. Referans4 Zapata H, Edwards JE, Titus JL. Aberrant right subclavian artery with left aortic arch: associated cardiac anomalies. Pediatr Cardiol. Jul 1993;14:159-161. doi: 10.1007/BF00795645.
  5. Referans5 Chaoui R, Heling KS, Sarioglu N, Schwabe M, Dankof A, Bollmann R. Aberrant right subclavian artery as a new cardiac sign in second- and third-trimester fetuses with Down syndrome. Am J Obstet Gynecol 2005;192:257–263. doi: 10.1016/j.ajog.2004.06.080.
  6. Referans6 Paladini D, Sglavo G, Pastore G, Masucci A, D'Armiento MR, Nappi C. Aberrant right subclavian artery: incidence and correlation with other markers of Down syndrome in second-trimester fetuses. Ultrasound Obstet Gynecol. 2012;39:191-195. doi: 10.1002/uog.10053.
  7. Referans7 Gardiner H, Chaoui R. The fetal three-vessel and tracheal view revisited. Semin Fetal Neonatal Med 2013;18:261-268. doi: 10.1016/j.siny.2013.01.007.
  8. Referans8 Willruth AM, Dwinger N, Ritgen J, Stressig R, Gelpel A, Gembruch U, Berg C: Fetal aberrant right subclavian artery (ARSA) – a potential new soft marker in the genetic scan? Ultraschall Med 2012;33:E114–E118.

Details

Primary Language

English

Subjects

Obstetrics and Gynaecology

Journal Section

Research Article

Publication Date

January 4, 2021

Submission Date

June 18, 2020

Acceptance Date

November 23, 2020

Published in Issue

Year 2021 Volume: 14 Number: 1

AMA
1.Demir E, Ekmekci E, Kelekcı S. Aberrant right subclavian artery: is a strong marker for Down syndrome and congenital heart disease? Pam Med J. 2021;14(1):185-190. doi:10.31362/patd.753921

Creative Commons Lisansı
Pamukkale Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License